A phase 3 open-label, controlled, randomized trial evaluating the efficacy and safety of a bioengineered allogeneic cellularized construct in patients with deep partial-thickness thermal burns.

Document Type

Conference Proceeding

Publication Date

4-1-2021

Publication Title

Journal of Burn Care & Research

Abstract

American Burn Association 53rd Annual Meeting

First Page

S25

Last Page

S26

Volume

42

Issue

Supplement 1

Comments

Abstract Number: 31

Share

COinS